Recent Research | Page 71 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Titlesort descending Original Publication Date Journal Bone Marrow Disease
The immune landscape of myelodysplastic syndromes Nov 2016 Crit Rev Oncol Hematol myelodysplastic syndromes (MDS)
The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline. Aug 2012 Crit Rev Oncol Hematol aplastic anemia
The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany. Sep 2013 Eur J Haematol myelodysplastic syndromes (MDS)
The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes Aug 2012 Leuk Res myelodysplastic syndromes (MDS)
The impact of myelodysplastic syndromes on quality of life: lessons learned from 70 voices Jan 2012 J Support Oncol myelodysplastic syndromes (MDS)
The Impact of Somatic and Germline Mutations in Myelodysplastic Syndromes and Related Disorders Jan 2017 J Natl Compr Canc Netw myelodysplastic syndromes (MDS)
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail Mar 2017 Oncologist myelodysplastic syndromes (MDS)
The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression Aug 2017 Exp Hematol myelodysplastic syndromes (MDS)
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes Jan 2015 Leuk Res myelodysplastic syndromes (MDS)
The molecular pathogenesis of the myelodysplastic syndromes Jan 2015 Eur J Haematol myelodysplastic syndromes (MDS)